AgressC. M., JacobH. I., GlassnerH. E., LedererM. A., ClarkW. G., WroblewskiF., KarmenA., La DueJ. S.: Serum glutamic oxaloacetic transaminase activity in conditions associated with myocardial infarction. II. Cerebral vascular accidents and congestive heart failure. Ann. Int. Med., 16; 197 (1957).
2.
CohenL.: Serumi enzyme determinations: their reliability and value. Med. Clin. N. Amer., 53; 115 (1969).
3.
DreyfusJ. C., SchapiraG., DemosJ.: Étude de la creatine-kinase serique chez les myopathes et leurs familles. Rev. Franç. Études Clin. Biol., 5; 384 (1960).
4.
DreyfusJ. C., SchapiraG., ResnaisJ., ScebatL.: La créatine-kinase serique dans le diagnostic de l'infarctus myocardique. Rev. Franç. Études Clin. Biol., 5; 386 (1960).
5.
FrskA. A., ThomasR. G.: Serum transaminase values after cholecystectomy, hysterectomy and operation on the fractured hip. Am. J. Med. Sc., 236; 133 (1958).
6.
GriffithsP. D.: ATP: creatine phosphotransferase in the diagnosis of acute chest pain. Brit. Heart J., 28; 199 (1966).
7.
Idem:Serum levels of ATP: creatine-phosprotransferase (creatine-kinase). The normal range and effect of muscolar activity. Clin. Crim. Acta, 13; 413 (1966).
8.
HarrahJ. D., HolmesE. C., PaulsonD. F., KetchamA. S.: Serum enzyme alterations after extensive surgical procedures. Amer. J. Surg., 169; 300 (1969).
9.
HessJ. W., Mac DonaldR. P., FrederickR. J., JonesR. N., NeelyJ., GrossD.: Serum creatine phosprokinase (CPK) activity in disorders of heart and skeletal muscle. Am. Intern. Med., 61; 1015 (1964).
10.
La DueJ. S., WroblewskiF.: Serum glutamic oxaloacetic transaminase variations in heart and liver disease. A.M.A. Scientific Exibition, p. 297, Grune Stratton, 1955.
11.
La DueJ. S., WroblewskiF., NydickJ.: Serum glutamic oxaloacetic transaminase activity as an index of acute myocardial damage. Mod. Cone. Cardiovas. Dis., 25; 333 (1956).
12.
La DueJ. S., WroblewskiF., KarmenA.: Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science, 120; 497 (1954).
13.
La DueJ. S., BurckhardtD., NydickI.: Enzymatic assessment of myocardial damage. Geriatrics, 22; 184 (1967).
14.
MarmarJ. L., KarafinL., KendallA R.: The activity or serum enzymes following prostatic operation. J. Urol., 102; 84 (1969).
15.
NickelW. K., AlbrittenF. F.: Serum transaminase content related to tissue injury. Surgery, 42; 240 (1957).
16.
PersonD. A., JudgeR. D.: Effect of operation on serum transaminase levels. Arch. Surg., 77; 892 (1958).
ReaganJ. R., TaylorF. W., HiggsR. E., DaydenC. B., IrvineE. W., IrvineE. S.: Serum glutamic oxaloacetic transaminase (SGO-T) determinations in prostatic surgery: report of cases. J. Urol., 85; 334 (1961).
19.
SavignanoT., HanokA., KuoJ.: Creatine Phosphokinase activity. A study of normal and abnormal levels. Am. J. Clin. Path., 51; 76 (1969).
20.
ShawR. F., PearsonC. M., ChowdhuryS. R., DreifussF. E.: Serum enzymes in sexlinked (Duchenne) muscular dystrophy. Arch. Neurol., 16; 115 (1967).
21.
SmithA. F.: Diagnostic value of serum creatine-kinase in a coronary care unit. Lancet, 2; 178 (1967).
22.
VincentW. R., RapapaortE.: Serum creatine Phosphokinase in the diagnosis of acute myocardial infarction. Amer. J. Cardiol., 15; 17 (1965).
23.
WroblewskiF., La DueJ. S.: Serum glutamic pyruvic transaminase in cardiac and hepatic disease. Proc. Soc. Exp. Biol. Med., 91; 569 (1956).
24.
WroblewskiF.: Clinical significance of serum enzyme alterations associated with myocardial infarction. Amer. Heart. J., 54, 219 (1957).
25.
WroblewskiF., GreforyK. F.: Lactic dehydrogenase isozymes and their distribution in normal tissues and plasma and in disease states. Ann. N.Y. Acad. Sc., 94; 868 (1961).
